Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Elite Pharmaceuticals has signed a commercial manufacturing and supply pact with Mikah Pharma.
Subscribe to our email newsletter
As per the terms of the agreement, Elite will conduct the laboratory stability studies, manufacturing and packaging for two generic products: Isradipine capsules USP, 2.5mg and 5mg and Phendimetrazine Tartrate tablets USP, 35mg.
Elite will be compensated at an agreed upon transfer price for the manufacturing and packaging of the products.
Elite is eligible to receive a 10% royalty on net profits for Isradipine finished products from Mikah and will also receive a onetime milestone payment for each product for the work associated with the technology transfer.